GlassScriptPhysician profile
Flannery E Fielding
NPI 1881979110
$2,438.28
in general payments reported to CMS, 2019-2025
21 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $511 · 2024: $707 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,318.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $660.28 | 2022-2025 | |
| Teleflex LLC | $325.27 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $302.18 | 2023-2025 | Gemtesa |
| Coloplast Corp | $214.20 | 2024-2025 | |
| Kerecis Limited | $186.74 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $147.30 | 2024-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Lithovue |
| Bluewind Medical | $139.68 | 2025 | Revi |
| Endo USA, INC. | $100.82 | 2024-2025 | Xiaflex |
| Astellas Pharma US INC | $56.29 | 2023-2024 | Veozah |
| Tolmar, INC. | $46.92 | 2023-2025 | Jatenzo, Eligard |
| Becton, Dickinson and Company | $39.81 | 2025 | Bard Urinary Drainage Bag |
| Access Pro Medical, LLC | $37.69 | 2025 | Matriderm |
| Photocure INC | $32.67 | 2023-2024 | Cysview |
| Urogen Pharma, INC. | $27.94 | 2025 | |
| Axonics, INC. | $22.03 | 2024 | Axonics |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $19.25 | 2022 | |
| Sagent Pharmaceuticals | $17.26 | 2023 | Glydo |
| Immunitybio, INC. | $17.19 | 2024 | |
| Janssen Biotech, INC. | $16.24 | 2025 | Erleada |
| Abc Home Medical Supply, INC. | $15.29 | 2025 | |
| Koelis INC. | $13.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flannery Fielding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.